Lipoprotein composition HDL particle size distribution women non-insulin-dependent diabetes mellitus effects probucol treatment spectrum atherogenic disturbances lipoprotein composition non-insulin-dependent diabetes NIDDM subset women NIDDM treatment lipophilic lipid-lowering drug probucol gm day corrects certain compositional abnormalities women share subjects treatment NIDDM group plasma level mg/dl control mg/dl mean SD controls cholesterol high-density lipoprotein cholesterol HDL-C levels control levels number significant disturbances present surface core lipid composition lipoproteins cholesterol content NIDDM low-density lipoprotein LDL similar controls content sphingomyelin phosphatidylinositol phosphatidylserine sphingomyelin-to-lecithin ratio very-low-density lipoprotein VLDL amounts free unesterified cholesterol FC Probucol therapy significant decreases total plasma cholesterol FC HDL-C triglyceride apoproteins A-I apo A-I diabetic control probucol hemoglobin cholesterol probucol 